Reuters logo
BRIEF-Global Blood Therapeutics expands ongoing Phase 2A hope-kids 1 study into younger pediatric population
July 10, 2017 / 12:17 PM / 3 months ago

BRIEF-Global Blood Therapeutics expands ongoing Phase 2A hope-kids 1 study into younger pediatric population

July 10 (Reuters) - Global Blood Therapeutics Inc

* Global Blood Therapeutics expands ongoing phase 2A hope-kids 1 study into younger pediatric population

* Global Blood Therapeutics Inc - it has expanded ongoing hope-kids 1 study (GBT440-007) to include a new single-dose cohort in children age 6 to 11 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below